Article Information
History
- June 1, 2024.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. This article is a US Government work. It is not subject to copyright under 17 USC 105 and is also made available for use under a CC0 license.
Author Information
- Jun Soo Lee, PhD1,*,
- Yidan (Xue) Zhang, PhD1,2,
- Yu Wang, PhD3,4,
- Joohyun Park, PhD5,
- Ashutosh Kumar, PhD1,6,
- Bruce Donald, MA1,2,
- Feijun Luo, PhD1 and
- Kakoli Roy, PhD7,#
- 1Division for Heart Disease and Stroke Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia
- 2ASRT, Inc., Atlanta, Georgia
- 3Division of Workforce Development, Centers for Disease Control and Prevention, Atlanta, Georgia
- 4Data Science and Evaluation Team, American Heart Association, Dallas, Texas
- 5Division of Drug Overdose Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia
- 6Bizzell US, New Carrollton, Maryland
- 7National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia
- ↵*Corresponding author: Jun Soo Lee, PhD, Division for Heart Disease and Stroke Prevention Centers for Disease Control and Prevention, 4770 Buford Hwy, Building 107, Atlanta, GA 30341, Tel: 770-488-8978, Email: PQA2{at}cdc.gov
Posted June 01, 2024.
Medical Costs, Health Care Utilization, and Productivity Losses Associated With Hypertension by COVID-19 Among US Commercial Enrollees
